Evidence map›Paper›PMID 32795303›Full record

ArticleBMC medicine2020

Indirect implications of COVID-19 prevention strategies on non-communicable diseases : An Opinion Paper of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk Assessment in Subjects Living in or Emigrating from Low Resource Settings.

Pietro A Modesti, Jiguang Wang, Albertino Damasceno, Charles Agyemang, Luc Van Bortel, Alexandre Persu, Dong Zhao, Faical Jarraya, Ilaria Marzotti, Mohamed Bamoshmoosh and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Health Services Utilization in China during the COVID-19 Pandemic: Results from a Large-Scale Online Survey.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 9 countries.

Pietro A ModestiDepartment of Experimental and Clinical Medicine, School of Medicine, Universita' degli Studi di Firenze, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy. pa.modesti@unifi.it.ORCID 0000-0002-9511-2173
Jiguang WangThe Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Albertino DamascenoDepartment of Cardiology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Charles AgyemangDepartment of Public & Occupational Health, Amsterdam Public Health (APH) Research Institute, Amsterdam University Medical Centres, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, the Netherlands.
Luc Van BortelDivision of Clinical Pharmacology, Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium.
Alexandre PersuDivision of Cardiology, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
Dong ZhaoDepartment of Epidemiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Faical JarrayaUniversité de Sfax, Laboratoire de Recherche LR19ES11 (Ex. UR12ES14), Faculté de Médecine, Avenue M. Boulila, Sfax, 3029, Tunisie.
Ilaria MarzottiDepartment of Experimental and Clinical Medicine, School of Medicine, Universita' degli Studi di Firenze, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
Mohamed BamoshmooshUniversity of Science and Technology, Sana'a, Yemen.
Gianfranco ParatiDepartment of Medicine and Surgery, University of Milano-Bicocca, Department of Cardiology, S. Luca Hospital, IRCCS Istituto Auxologico Medicine and Surgery, Milan, Italy.
Aletta E SchutteHypertension in Africa Research Team, North-West University, Potchefstroom, South Africa.
Azienda Ospedaliero-Universitaria Careggi · ITCapital Medical University · CNCliniques Universitaires Saint-Luc · BEEduardo Mondlane University · MZGhent University · BEIRCCS Istituto Auxologico Italiano · ITNorth-West University · ZARuijin Hospital · CNUniversity of Amsterdam · NLUniversity of Science and Technology · YEUniversity of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter its outbreak in China, the novel COronaVIrus Disease 19 is spreading across the globe. It is an emergency the world has never seen before. MAIN TEXT: The attention of health systems is mainly focused on COronaVIrus Disease 19 patients and on the risk that intensive care units might be overwhelmed by the serious pulmonary complications. Different countries are also attempting to establish infection prevention and control strategies which proved effective in China where the outbreak was initially reported. We reflect on important lessons to be learnt from different countries. The effects that infection prevention and control strategies, such as social distancing or isolation, can have on the care of millions of patients with non-communicable diseases, who may be indirectly affected, have not been taken into consideration so much.

conclusionsWhen dealing with COronaVIrus Disease 19, policy makers and healthcare personnel should consider the indirect effects on the treatment of non-communicable diseases.

Indexed as

BetacoronavirusCardiovascular DiseasesHypertensionNoncommunicable DiseasesChinaCoronavirus InfectionsCOVID-19Emigration and ImmigrationHealth ResourcesHumansPandemicsPneumonia, ViralRisk AssessmentRisk FactorsSARS-CoV-2CancerCardiovascular diseaseCoronavirusCOVID-19DiabetesHypertensionNon-communicable diseasesRespiratory diseaseSARS-CoV-2

Identifiers

PMID32795303
PMCPMC7426897
OpenAlexW3048689962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.